Am80, a retinoic acid receptor agonist, ameliorates murine vasculitis through the suppression of neutrophil migration and activation

Arthritis and Rheumatism

Volumn 65, Issue 2, 2013, Pages 503-512

  Miyabe, Chie ^a   Miyabe, Yoshishige ^a   Miura, Noriko N ^b   Takahashi, Kei ^c   Terashima, Yuya ^d   Toda, Etsuko ^d   Honda, Fumiko ^a   Morio, Tomohiro ^a   Yamagata, Naoko ^e   Ohno, Naohito ^b   Shudo, Koichi ^e   Suzuki, Jun Ichi ^d   Isobe, Mitsuaki ^a   Matsushima, Kouji ^d   Tsuboi, Ryoji ^a   Miyasaka, Nobuyuki ^a   Nanki, Toshihiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^c TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e Kawasaki   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE ANTIBODY; LEUKOCYTE ELASTASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN; TAMIBAROTENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTICLE; CANDIDA ALBICANS; CELL MOTILITY; CORONARY ARTERY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; LEUKOPENIA; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VASCULITIS;

ANIMALS; AORTA; BENZOATES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HUMANS; MICE; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RECEPTORS, RETINOIC ACID; TETRAHYDRONAPHTHALENES; VASCULITIS;

EID: 84873854711     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37784     Document Type: Article

References (49)

1. Watts RA, Scott DG,. Recent developments in the classification and assessment of vasculitis. Best Pract Res Clin Rheumatol 2009; 23: 429-43.
2. Heimburger M, Larfars G, Bratt J,. Prednisolone inhibits cytokine-induced adhesive and cytotoxic interactions between endothelial cells and neutrophils in vitro. Clin Exp Immunol 2000; 119: 441-8.
3. Takahashi K, Oharaseki T, Yokouchi Y, Miura NN, Ohno N, Okawara AI, et al. Administration of human immunoglobulin suppresses development of murine systemic vasculitis induced with Candida albicans water-soluble fraction: an animal model of Kawasaki disease. Mod Rheumatol 2010; 20: 160-7.
4. Nagi-Miura N, Shingo Y, Adachi Y, Ishida-Okawara A, Oharaseki T, Takahashi K, et al. Induction of coronary arteritis with administration of CAWS (Candida albicans water-soluble fraction) depending on mouse strains. Immunopharmacol Immunotoxicol 2004; 26: 527-43.
5. Kurihara K, Shingo Y, Miura NN, Horie S, Usui Y, Adachi Y, et al. Effect of CAWS, a mannoprotein-β-glucan complex of Candida albicans, on leukocyte, endothelial cell, and platelet functions in vitro. Biol Pharm Bull 2003; 26: 233-40.
6. Takahashi K, Oharaseki T, Wakayama M, Yokouchi Y, Naoe S, Murata H,. Histopathological features of murine systemic vasculitis caused by Candida albicans extract-an animal model of Kawasaki disease. Inflamm Res 2004; 53: 72-7.
7. Miura NN, Komai M, Adachi Y, Osada N, Kameoka Y, Suzuki K, et al. IL-10 is a negative regulatory factor of CAWS-vasculitis in CBA/J mice as assessed by comparison with Bruton's tyrosine kinase-deficient CBA/N mice. J Immunol 2009; 183: 3417-24.
8. Ishida-Okawara A, Nagi-Miura N, Oharaseki T, Takahashi K, Okumura A, Tachikawa H, et al. Neutrophil activation and arteritis induced by C. albicans water-soluble mannoprotein-β-glucan complex (CAWS). Exp Mol Pathol 2007; 82: 220-6.
9. Chambon P,. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940-54.
10. Tabin CJ,. Retinoids, homeoboxes, and growth factors: toward molecular models for limb development. Cell 1991; 66: 199-217.
11. Mora JR, Iwata M, von Andrian UH,. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8: 685-98.
12. Mehta K, McQueen T, Tucker S, Pandita R, Aggarwal BB,. Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. J Leukoc Biol 1994; 55: 336-42.
13. Becherel PA, Mossalayi MD, LeGoff L, Frances C, Chosidow O, Debre P, et al. Mechanism of anti-inflammatory action of retinoids on keratinocytes. Lancet 1994; 344: 1570-1.
14. Gu B, Zhu Y, Zhu W, Miao J, Deng Y, Zou S,. Retinoid protects rats against neutrophil-induced oxidative stress in acute experimental mastitis. Int Immunopharmacol 2009; 9: 223-9.
15. Camisa C, Eisenstat B, Ragaz A, Weissmann G,. The effects of retinoids on neutrophil functions in vitro. J Am Acad Dermatol 1982; 6: 620-9.
16. Bohne M, Struy H, Gerber A, Gollnick H,. Effects of retinoids on the generation of neutrophil-derived reactive oxygen species studied by EPR spin trapping techniques. Inflamm Res 1997; 46: 423-4.
17. Coble BI, Dahlgren C, Molin L, Stendahl O,. Neutrophil function in psoriasis: effects of retinoids. Acta Derm Venereol 1987; 67: 481-90.
18. Van de Kerkhof PC,. Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol Ther 2006; 19: 252-63.
19. Smith EV, Grindlay DJ, Williams HC,. What's new in acne? An analysis of systematic reviews published in 2009-2010. Clin Exp Dermatol 2011; 36: 119-22.
20. Kagechika H,. Novel synthetic retinoids and separation of the pleiotropic retinoidal activities. Curr Med Chem 2002; 9: 591-608.
21. Ohnishi K,. PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia. Int J Clin Oncol 2007; 12: 313-7.
22. Miwako I, Kagechika H,. Tamibarotene. Drugs Today (Barc) 2007; 43: 563-8.
23. Uchiyama M, Ohno N, Miura NN, Adachi Y, Aizawa MW, Tamura H, et al. Chemical and immunochemical characterization of limulus factor G-activating substance of Candida spp. FEMS Immunol Med Microbiol 1999; 24: 411-20.
24. Hao Q, Chen Y, Zhu Y, Fan Y, Palmer D, Su H, et al. Neutrophil depletion decreases VEGF-induced focal angiogenesis in the mature mouse brain. J Cereb Blood Flow Metab 2007; 27: 1853-60.
25. Honda F, Kano H, Kanegane H, Nonoyama S, Kim ES, Lee SK, et al. The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils. Nat Immunol 2012; 13: 369-78.
26. Nanki T, Nagasaka K, Hayashida K, Saita Y, Miyasaka N,. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol 2001; 167: 5381-5.
27. Terashima Y, Onai N, Murai M, Enomoto M, Poonpiriya V, Hamada T, et al. Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis. Nat Immunol 2005; 6: 827-35.
28. Sugitani M, Abe R, Ikarashi N, Ito K, Muratake H, Shudo K, et al. Disposition of a new tamibarotene prodrug in mice. Biol Pharm Bull 2009; 32: 1997-2001.
29. Kirchmeyer M, Koufany M, Sebillaud S, Netter P, Jouzeau JY, Bianchi A,. All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation. Arthritis Res Ther 2008; 10: R141.
30. Sah JF, Eckert RL, Chandraratna RA, Rorke EA,. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation. J Biol Chem 2002; 277: 9728-35.
31. Kim MS, Kim YK, Eun HC, Cho KH, Chung JH,. All-trans retinoic acid antagonizes UV-induced VEGF production and angiogenesis via the inhibition of ERK activation in human skin keratinocytes. J Invest Dermatol 2006; 126: 2697-706.
32. McCarroll JA, Phillips PA, Santucci N, Pirola RC, Wilson JS, Apte MV,. Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis. Gut 2006; 55: 79-89.
33. Komi Y, Sogabe Y, Ishibashi N, Sato Y, Moriwaki H, Shimokado K, et al. Acyclic retinoid inhibits angiogenesis by suppressing the MAPK pathway. Lab Invest 2010; 90: 52-60.
34. Carlson JA,. The histological assessment of cutaneous vasculitis. Histopathology 2010; 56: 3-23.
35. Malech HL, Gallin JI,. Neutrophils in human diseases. N Engl J Med 1987; 317: 687-94.
36. Sharma A, Lewandoski JR, Zimmerman JJ,. Retinol inhibition of in vitro human neutrophil superoxide anion release. Pediatr Res 1990; 27: 574-9.
37. Bainton DF, Ullyot JL, Farquhar MG,. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 1971; 134: 907-34.
38. Kennedy AD, DeLeo FR,. Neutrophil apoptosis and the resolution of infection. Immunol Res 2009; 43: 25-61.
39. Dedieu S, Lefebvre P,. Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. Cell Signal 2006; 18: 889-98.
40. phox phosphorylation in human neutrophils. J Immunol 2000; 165: 5238-44.
41. phox by p38 and ERK but not by JNK. Arch Biochem Biophys 1996; 334: 395-400.
42. Murata H, Iijima H, Naoe S, Atobe T, Uchiyama T, Arakawa S,. The pathogenesis of experimental arteritis induced by Candida alkali-extract in mice. Jpn J Exp Med 1987; 57: 305-13.
43. Murata H, Naoe S,. Experimental Candida-induced arteritis in mice-relation to arteritis in Kawasaki disease. Prog Clin Biol Res 1987; 250: 523.
44. Gauglitz GG, Callenberg H, Weindl G, Korting HC,. Host defence against Candida albicans and the role of pattern-recognition receptors. Acta Derm Venereol 2011; 92: 291-8.
45. Ohyanagi N, Ishido M, Suzuki F, Kaneko K, Kubota T, Miyasaka N, et al. Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody production in vivo. Arthritis Rheum 2009; 60: 3118-27.
46. Klemann C, Raveney BJ, Klemann AK, Ozawa T, von Horsten S, Shudo K, et al. Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis. Am J Pathol 2009; 174: 2234-45.
47. Nagai H, Matsuura S, Bouda K, Takaoka Y, Wang T, Niwa S, et al. Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice. Pharmacology 1999; 58: 101-12.
48. Sato A, Watanabe K, Kaneko K, Murakami Y, Ishido M, Miyasaka N, et al. The effect of synthetic retinoid, Am80, on T helper cell development and antibody production in murine collagen-induced arthritis. Mod Rheumatol 2010; 20: 244-51.
49. Nishimori H, Maeda Y, Teshima T, Sugiyama H, Kobayashi K, Yamasuji Y, et al. Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by downregulating Th1 and Th17. Blood 2011; 119: 285-95.